A Different Hue
We. Need. More.
So we're changing our colors.
Pink and October are both important reminders that the battle against breast cancer is still in full force. It has already robbed us all of too many incredible women, and despite growing efforts to find a cure, this disease is still on the rise. In 2017, an estimated 252,710 new cases of invasive breast cancer are expected to be diagnosed in women in the U.S. and about 2,470 new cases of invasive breast cancer in men.
That is why this month we will #WearADifferentHue of pink to draw attention to a different side of breast cancer awareness.. the need for more research into antiperspirants and their possible contribution to this devastating disease. The widely available rhetoric is that it hasn't been proven so antiperspirants are safe on that basis, but we're the girls and this is our era. We're aware of our bodies & and our decisions are conscious and informed. We refuse to be told not to worry when the evidence so far says that maybe we should.
This October on our blog will be examining the existing evidence to bring awareness to the need for more research into suspected cosmetic ingredients, specifically in antiperspirants/deodorants. Our goal is to eventually to gain real answers rather than the classic "hasn't been proven" line we're supposed to feel safe with, but are all tired of. Women deserve answers to these questions, not dismissal. As women ourselves, we feel that all of us have the right to our own bodies and health, and that every woman deserves a deodorant that protects her in every way.
Through October all of our deodorant labels will rock a "Different Hue" of pink, and $1 of every deodorant sold will go to the Fred Hutchinson Cancer Research Foundation because of their unique approach and focus on less common subjects of breast cancer prevention and treatment. You can check it out here:
Stay tuned to get the scoop on what we've found and why it matters. Let's raise awareness together.
#WearADifferentHue
Leave a comment
Please note, comments must be approved before they are published